Last reviewed · How we verify

NCT07240129

Effect of Graded Motor Imagery on Shoulder Dysfunction Post Mastectomy

Active, enrolled NA Last updated 20 November 2025
What this trial tests

NA trial testing Graded Motor Imagery (GMI) in Shoulder Dysfunction in 54 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
30 April 2025
Primary endpoint
30 April 2026
30 April 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment54
Start date30 April 2025
Primary completion30 April 2026
Estimated completion30 April 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 35 to 55, female only, with Shoulder Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One of the most common complications after breast cancer surgery is a functional limitation of the upper body. Up to 67% of breast cancer patients experience arm or shoulder impairment, including pain, numbness, loss of strength, and reduced ROM, after surgery. Graded motor imagery is effective in reducing pain interference with function using a graded sequence of strategies including left/right judgements (implicit motor imagery), imagined movements (explicit motor imagery) and mirror therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Graded Motor Imagery (GMI)

Trials testing the same drug.

Other recruiting trials for Shoulder Dysfunction

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07240129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing